A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
NCT07532434 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 480
Last updated 2026-04-15
Summary
The goal of this multi-center observational study is to learn about the effectiveness and safety of different prophylactic (preventive) surgical options in women at moderate-to-high genetic risk for hereditary ovarian cancer (HOC).
The main questions it aims to answer are:
Does individualized prophylactic surgery (such as removing fallopian tubes now and delaying ovary removal) effectively reduce the risk of developing ovarian cancer compared to standard care or close monitoring?
How do these different surgical interventions affect a woman's ovarian function and quality of life?
What Participants Will Do:
Participants who are healthy carriers of specific genetic mutations (such as BRCA1/2, RAD51C/D, etc.) will be followed in a bidirectional cohort. Depending on the medical care and surgical path they choose with their doctors (Standard RRSO, Delayed Oophorectomy, or Close Monitoring), researchers will collect their clinical data, surgical pathology results, and follow-up information regarding cancer incidence and quality of life for 3 years.
Conditions
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2026-09-30
- Completion
- 2035-09-30
Countries
- China
Study Locations
More Related Trials
-
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
NCT05200260 ·Status: RECRUITING ·Phase: PHASE2
-
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Survival Outcomes of Ovarian Malignancies in Chinese Population
NCT03291262 ·Status: UNKNOWN
-
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
NCT05827523 ·Status: RECRUITING ·Phase: PHASE3
-
Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07031908 ·Status: NOT_YET_RECRUITING
-
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer
NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3
-
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
NCT05287451 ·Status: RECRUITING ·Phase: NA
-
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03180177 ·Status: UNKNOWN ·Phase: PHASE3
-
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
NCT06385912 ·Status: COMPLETED
-
Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer
NCT05523804 ·Status: UNKNOWN
-
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3
-
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
NCT05633199 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
NCT03296826 ·Status: RECRUITING
-
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
NCT04470921 ·Status: ACTIVE_NOT_RECRUITING
-
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
NCT05704621 ·Status: RECRUITING ·Phase: PHASE2
-
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
NCT06292286 ·Status: RECRUITING ·Phase: NA
-
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
NCT01611766 ·Status: UNKNOWN ·Phase: PHASE3
-
Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
NCT02291276 ·Status: WITHDRAWN
-
Prophylactic Salpingectomy With Delayed Oophorectomy
NCT01907789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NCT02828618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genomic BRCA and Extensive ovArian Cancer Testing
NCT04027868 ·Status: COMPLETED
-
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
NCT07125391 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED